Action DOD DOD BIOTECH
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues DOD Biotech

Actions

DOD

TH8569010003

Cours en clôture Thailand S.E.
Autres places de cotation
 00:00:00 07/05/2024 		Varia. 5j. Varia. 1 janv.
2,8 THB +3,70 % Graphique intraday de DOD Biotech +6,06 % -24,32 %
02/04 DOD Biotech Public Company Limited annonce la démission d'Aekphusit Boonsiriyotthakul de ses fonctions de directeur, de directeur exécutif et de directeur des opérations CI
23/02 DOD Biotech Public Company Limited publie ses résultats pour l'exercice clos le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
DOD Biotech Public Company Limited Announces Aekphusit Boonsiriyotthakul of Director, Executive Director, and Chief Operating Officer
DOD Biotech Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Kiatnakin Phatra Asset Management Company Limited acquired 19.52% stake in DOD Biotech Public Company Limited from Lampun Puntanaprates.
DOD Biotech Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
DOD Biotech Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
DOD Biotech Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
DOD Biotech Public Company Limited announced that it expects to receive THB 99.999 million in funding
DOD Biotech Public Company Limited announced that it expects to receive THB 500 million in funding
DOD Biotech Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022
DOD Biotech Public Company Limited Approves Establishment of A Subsidiary
DOD Biotech Public Company Limited Establishes New Subsidiary
DOD Biotech Public Company Limited Announces Executive Changes
DOD Biotech Public Company Limited Announces Management Changes
DOD Biotech Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
DOD Biotech Public : Report use of proceeds from initial public offering of ordinary shares
DOD Biotech Public Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022
DOD Biotech Public : New shares of DOD to be traded on June 22, 2022
DOD Biotech Public : Report on the results of the Exercise of DOD-W2 (F53-5) (Revision)
DOD Biotech Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022
DOD Biotech Public Company Limited Announces Executive Changes
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action DOD
  4. Actualités DOD Biotech
  5. Autres langues